
Renke Bio
人科生物
Renke Bio
Materials/Deep Tech
Renke Biotech has developed a fundamentally new approach to cancer genetic testing, using blood-based cfDNA open chromatin region detection for early screening of individual cancers and multiple cancer types. The method is simple to use and low-cost, addressing challenges such as the difficulty of…
Latest round: Angel (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.